NAME: ________________________

Question Types


Start With


Question Limit

of 60 available terms

Advertisement Upgrade to remove ads

5 Written Questions

5 Matching Questions

  1. 2403.01
  2. 2407.02
  3. 2411
  4. 2422.07
  5. 2435
  1. a Examination Procedures
  2. b Publishing of Patents and Patent Application Publications With Lengthy Sequence Listings
  3. c Replacement or Supplemental of Deposit
    AFTER A PATENT HAS ISSUED
  4. d Requirements for Compliance, Statements Regarding New Matter, and Sanctions for Failure to Comply
  5. e Material Capable of Self-Replication

    Biological material includes material that is capable of self-replication either directly or indirectly.

5 Multiple Choice Questions

  1. Rejections Based on Deposit Issue
  2. Nucleotide and/or Amino Acid Sequence Disclosures in Patent Disclosure in Patent Applications
  3. Replacement or Supplement of Deposit
    IN A PENDING APPLICATION
  4. Requirement for Statement Regarding Content of Official and Computer Readable Copies of Sequence Listing
  5. The Deposit Rules

    Where the invention involves a biological material and words alone cannot sufficiently describe how to make and use the invention in a reproducible manner, access to the biological material may be necessary for the satisfaction of the statutory requirements for patentability under 35 U.S.C. 112.

5 True/False Questions

  1. 2422.05Reference to Previously Filed Identical Computer Readable Form; Continuing or Dericatiove Applications; Request for Transfer of Computer Readable Form

          

  2. 2407Acceptable Depository

    The depository must:
    (i)Have a continuous existence;
    (ii)Exist independent of the control of the depositor;
    (iii)Possess the staff and facilities sufficient to examine the viability of a deposit and store the deposit in a manner which ensures that it is kept viable and uncontaminated;
    (iv)Provide for sufficient safety measures to minimize the risk of losing biological material deposited with it;
    (v)Be impartial and objective;
    (vi)Furnish samples of the deposited material in an expeditious and proper manner; and
    (vii)Promptly notify depositors of its inability to furnish samples, and the reasons why.

          

  3. 2434Examination of Patent Applications Claiming Large Numbers of Nucleotide Sequences

    Nucleotide sequences encoding different proteins are structurally distinct chemical compounds and are unrelated to one another. These sequences are thus deemed to normally constitute independent and distinct inventions within the meaning of 35 U.S.C. 121. Absent evidence to the contrary, each such nucleotide sequence is presumed to represent an independent and distinct invention, subject to a restriction requirement pursuant to 35 U.S.C. 121 and 37 CFR 1.141.

    applicants may petition pursuant to 37 CFR 1.181 for examination of additional nucleotide sequences by providing evidence that the different nucleotide sequences do not cover independent and distinct inventions.

          

  4. 2404.03Biological Material That Is Known and Readily Available to the Public

          

  5. hat is the mininum number of seeds that must be deposited to be considered by the Office?2500

          

Create Set